A B S T R A C T To determine whether renal prostaglandins participate in the regulation of renal blood flow during acute reduction of cardiac output, cardiac venous return was decreased in 17 anesthetized dogs by inflating a balloon placed in the thoracic inferior vena cava. This maneuver decreased cardiac output from 3.69±0.09 liters/min (mean±SEM) to 2. 15±0.19 liters/min (P < 0.01) and the mean arterial blood pressure from 132±4 to 111±5 mm Hg (P < 0.01) and increased total peripheral vascular resistance from 37.6±2.5 to 57.9±4.8 arbitrary resistance units (RU) (P < 0.01). In marked contrast, only slight and insignificant decreases in the renal blood flow from 224±16 to 203± 19 ml/min and renal vascular resistance from 0.66 ±0.06 to 0.61±0.05 arbitrary resistance units (ru) were observed during inflation of the balloon. Concomitant with these hemodynamic changes, plasma renin activity and plasma norepinephrine concentration increased significantly in both the arterial and renal venous bloods. Plasma concentration of prostaglandin E2 in renal venous blood increased from 34±6 to 129±24 pg/ml (P < 0.01). The subsequent administration of indomethacin or meclofenamate had no significant effect on mean arterial pressure, cardiac output, and total peripheral vascular resistance, but reduced renal blood flow from 203±19 to 156±21 ml/min (P < 0.01) and increased renal vascular resistance from 0.61±0.05 to 1.05±0.21 ru (P < 0.01). Simultaneously, the plasma concentration ofprostaglandin E2 in renal venous blood fell from 129±24 to 19±3 pg/ml (P < 0.01). Administration of indomethacin to five dogs without prior obstruction of the inferior vena cava had no effect upon renal blood flow or renal vascular resistance. The results indicate that acute reduction of cardiac output enhances renal renin secretion and the activity of the
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The absence of an increase in renal vascular resistance during acute heart failure is noteworthy since the renin-angiotensin and sympathetic nervous systems are known to be activated in this condition (7) (8) (9) . The high peripheral vascular resistance during acute heart failure is, at least in part, mediated by angiotensin II, a potent renal vasoconstrictor; the administration of the converting enzyme inhibitor during heart failure reduces total peripheral vascular resistance and blood pressure (7, 8) . The sympathetic nervous system is also likely to participate in the maintenance of the arterial pressure since elevated levels of plasma norepinephrine have been found in patients with heart failure (9).
Work by several laboratories has recently demonstrated that regulation of renal blood flow results from the interplay of vasoconstrictor and vasodilator factors. In particular, prostaglandins are known to be involved in renal blood flow control in a variety of conditions in which the renin-angiotensin system is activated. Although inhibition of the synthesis of prostaglandins has little or no effect upon renal blood flow during control conditions (10) (11) (12) , it elicits or augments the reductions of renal blood flow that occur during hemorrhagic hypotension (13, 14) , sodium depletion (15) , and in patients with cirrhosis and ascitis (16) .
The purpose of the present study was to determine whether the renal prostaglaindiins are involved in the maintenance of renal blood flow during an acute decrease of cardiac output. The experiments were carried out in anesthetized dogs in which cardiac output was decreased by preventing cardiac venous return by means of an inflatable l)alloon placed in the thoracic iniferior vena cava. Simultaineous mieasurements of arterial and rencal venous conceintratioins of prostaglaindin ES (PGE2)' and of plasmiia renin activity, as well as renal blood flow and systemic hemodynamics, were performed in control conditions, during acute heart failure and following the adimiinistration of inhibitors of prostaglandiin synthesis. 20 ,ul of 60% perchloric acidl an(l 50-/.I ali(qtuots of the dleprotei nize(l supernatanit fractioni vere assayed1 for norepinephirinie. Norepinephirine (100 pg) was added to one ali(quiot fromii each sample to serve as an interl)al stanidard. Blanks, preparre(d with 0.001 N HCI, were treate(1 in a fashioni simiiilar to that of plasimia. A reactioni mixture was prepare(l ain(l 100 ,ul of this mi.>xttire was pipetted into each san)ple to begin enzvmiatic 0-minethvlation. The (19) . The pH of the reatctioni miixtuire was 8.9. At the enicl of a 60-mimi incubation at 38°(', the reaction was terminated by the (dditioni of 100-,l 230 J. A. Oliver, R. R. SciaCCa, J. Pinito, a1td P. J. Cannon aliquots of 1 M sodium borate, pH 11.0, containing 2 mM normetanephrine. The 3H-0-methylated products of the reaction mixture were extracted into 3 ml of toluene-isoamyl alcohol (3:2, vol/vol). At this and each extraction step, the aqueous and organic phases were separated by centrifugation. After freezing the aqueous phase in a mixture of dry-iceacetone, the organic phase was decanted into 150 gl of 0.1 M acetic acid solution that partitioned the normetanephrine back into the aqueous phase. This phase was washed once with 2.5 ml of toluene-isoamyl alcohol ( (20) . Blood was collected in heparinized, chilled tubes containing 10 ,tg indomethacin/ml in blood. After separation, the plasma was stored at -20°C until assay time. To 2 ml of plasma, -1,000 cpm of [3H]PGE2 were added for recovery estimation. The samples were then acidified to pH 3.5 with formic acid and extracted with 5 ml of ethylacetate. The organic layer was then collected and dried under N2. The dried extracted samples were redissolved in 0.5 ml of 0.1 M phosphate buffer (pH 7.40) containing 0.1 mg/ml Brij 35 to facilitate PGE2 recovery. The mean±SD overall recovery of [3H]PGE2 from plasma after extraction was 95+7% (n = 19).
METHODS
After taking aliquots for recovery estimation, 100-,ul aliquots of sample were added to assay tubes containing -8,000 cpm of [3H]PGE2 (equivalent to 12 pg), dissolved in 100 ,ul of redistilled water, and 100 ,ul of diluted antisera in phosphate buffer. Standards containing 3-708 pg of unlabeled PGE2 were treated in a similar manner. After incubation for 10 min at room temperature followed by 2 h at 40C, the bound and free PGE2 were separated by a charcoal-dextran mixture. The final antisera dilution resulted in an initial binding of -40%.
Nonspecific binding was 2.1±1.2% (mean-SD; n = 10).
Standard curves were analyzed by the method of Rodbard and Hutt (21) which is a nonlinear transformation of the logitlog relationship. A 10% decrease in bound counts was observed at 3.4±0.1 pg (mean+SD; n = 5). The mean+SD amount of PGE2 required to displace zero point binding by 50%o was 28+12 pg (n = 10). Extraction blanks averaged <2 pg. The accuracy of the assay was assessed by the recoverv of standard amounts of PGE2 (9.4-944 pg) added to a plasma pool. Linear regression analysis of the recovery standards gave: y = 0.94x + 18 (r = 0.96; n = 28), where y is the amount of standard recovered and x is the amount of PGE2 added. The reproducibility of the assay was determined by measurements of aliquots of the same plasma pool. When eight aliquots were measured in the same assay run, the mean-SD concentration was 81±11 pg/ml; the intraassay coefficient of variation was 13%. When aliquots of three separate plasma pools were measured in different assay runs, the mean+SD concentrations were: 15±3 pg/ml (n = 8); 43+8 pg/ml (n = 7); 95±20 pg/ml (n = 7). The interassay coefficients of variation wvere 20, 19, and 21%, respectively.
Statistical analysis. All values are expressed as mean±SE\I. Data were analyzed by analysis of variance or a paired t test (22) . Differences wvere termed significant if the F or t value exceeded the 5% level. flow, glomerular filtration rate, urine flow, and urinary sodium excretion. Although the arterial hematocrit was significantly higher (Table I) , the average renal plasma flow, like renal blood flow, was not significantly lower than control during obstruction of the thoracic inferior vena cava (Table II) . The glomerular filtration rate fell significantly from 49+3 to 36+9 ml/min in response to caval obstruction (P < 0.01); the slight reduction in filtration fraction was not statistically significant. Urine flow rate, urinary sodium excretion and the fractional excretion of sodium fell significantly in response to acute heart failure. Inhibition of prostaglandin synthesis during obstruction of the thoracic inferior vena cava reduced renal plasma flow from 126 to 96 ml/min (P < 0.01) but produced no significant changes in glomerular filtration rate, filtration fraction, urinary flow rate, urinary sodium excretion rate, or fractional sodium excretion. Table III depicts the values of PRA in arterial and renal venous blood. During the control period, PRA in the renal vein blood (2.5 ng/ml per h) was slightly but significantly higher than arterial PRA (1.8 ng/ml per h); the renal secretion rate of renin averaged 95 U/min. Inflation of the balloon in the thoracic inferior vena cava resulted in significant increases in the PRA in arterial and renal venous blood; the rate of renal renin secretion increased from 95 to 1,795 U/min (P < 0.01). The subsequent administration of the inhibitors of prostaglandin synthesis had no significant effect upon the PRA in arterial or renal venous blood or the rate of renin secretion by the kidney. Table IV shows the plasma concentrations of norepinephrine in arterial and renal venous blood. Under control conditions, the concentration of norepinephrine in the renal venous plasma was significantly greater than that of arterial plasma (204 vs. 106 pg/ml; P < 0.01); the calculated net rate of norepinephrine overflow2 during control averaged 13,280 pg/min. After 2 Since norepinephrine is both metabolized and secreted by the mammalian kidney (23) , the calculated net rate of norepinephrine overflow would be expected to underestimate that fraction of neurotransmitter which is released in the kidney and escapes into the circulation. The quantities ofnorepinephrine metabolized and secreted in a single passage through the renal circulation is unknown; the term net rate of norepinephrine overflow as used in this paper carries no implications about the exact influence of arterial norepinephrine concentration upon renal venous norepinephrine concentration. partial obstruction ofthe thoracic inferior vena cava, the norepinephrine concentration in the arterial plasma increased significantly from 106 to 316 pg/ml (P < 0.05); the renal venous norepinephrine concentration also increased from 204 to 496 pg/ml (P < 0.01). Despite the fact that the average renal venous-arterial concentration difference rose during caval balloon inflation from 98 to 180 pg/ml, the increase in the net rate of renal norepinephrine overflow (from 13,280 to 67,971 pg/min) was not statistically significant. Following administration of the inhibitors of prostaglandin synthesis, there was no significant change in the norepinephrine concentration in arterial plasma, but there was a significant increase in the norepinephrine concentration in the renal venous plasma. This may have been due to the marked fall in renal blood flow (Table I) , since the renal venous-arterial norepinephrine concentration difference and the net rate of norepinephrine overflow from the kidney were unchanged after administration of the inhibitors of prostaglandin synthesis (Table IV) . Table V shows the concentration of PGE2 in arterial and renal venous plasma during obstruction of the thoracic inferior vena cava and during subsequent administration of the inhibitors of prostaglandin synthesis. The control renal venous concentration of PGE2 was not statistically different from the arterial PGE2 concentration. The calculated net rate of renal PGE2 secretion3 during the control period averaged 1,614 pg/min, a value not significantly different from zero. In response to obstruction of the thoracic inferior vena cava there was no significant change in arterial PGE2; however, the renal venous plasma PGE2 concentration increased markedly from 34 to 129 pg/ml (P < 0.01). Consequently, the net rate of renal PGE2 secretion rose from 1,614 to 11,743 pg/min (P < 0.01). The subsequent administration of indomethacin or meclofenamate did not change arterial PGE2, but greatly reduced the mean renal venous PGE2 concentration from 129 to 19 pg/ml (P < 0.01); the calculated net renal secretion of PGE2 was not different from zero after blockade of the prostaglandin synthesis. 3Because the kidney is rich in prostaglandin degradating enzymes (24) , similar uncertainties exist about the exact fate of arterial PGE2 entering the kidney, as in the case of norepinephrine. Thus, the exact influence of arterial PGE2 concentration upon renal venous PGE2 concentration is unknown. Table III for abbreviations.
RESULTS
Renal Prostaglandins during Acute Reduction of Cardiac Output Table III for abbreviations.
DISCUSS ION In the present study, the lowering of venous return to the heart by inflation of a balloon placed in the thoracic inferior vena cava decreased the cardiac output markedly (-42+4%; P < 0.01) and lowered the mean arterial pressure (-16±+3%; P < 0.01). (Fig. 1) . The increase in the total peripheral vascuilar resistance (57+-9%; P < 0.01) that accompanied these changes, did not include the renal circulation; after inflation of the balloon the renal blood flow fell only slightly and insignificantly from 224 to 203 ml/min (-8±7%) and the renal vascular resistance remained unchanged (-3±6%). These results, with respect to the renal circulation during an acute lowering of the cardiac output, are in agreement with data obtained by others in anesthetized dogs with acute partial constriction of the pulmonary artery (3, 4) ; and in unanesthetized dogs with ventricular bradycardia (5) , or with partial occlusion of the thoracic inferior vena cava (6) .
The absence ofrenal vasoconstriction during the acute reduction of cardiac output is noteworthy because arterial plasma renin activity and arterial plasma concentration of norepinephrine were markedly elevated in response to thoracic caval obstruction (Tables  III and IV) and because angiotensin II and norepinephrine are both renal vasoconstrictors (15) . During acute heart failure, the renal venous renin activity and renal venous plasma norepinephrine concentration increased above control values. Since we have previously shown that changes in renal venous norepinephrine concentration reflect changes in the frequency of renal nerve discharges (25) , the observation of enhanced renal venous norepinephrine concentration during obstruction of the vena cava demonstrates, for the first time, that the augmented sympathetic tone in acute heart failure includes the renal sympathetic nerves.
Two findings from the present study strongly suggest that enhanced renal prostaglandin synthesis was responsible for the lack of renal vasoconstriction observed during the acute fall in the cardiac output. First, inflation of the balloon in the vena cava resulted in a marked increase in the renal venous plasma concentration of PGE2 and the corresponding net rate of renal secretion (Table V) Fig. 1 , during inflation of the thoracic caval balloon, total peripheral vascular resistance was greatly increased (57+9%; P < 0.01), but renal vascular resistance was unchanged from control; the subsequent administration of inhibitors ofprostaglandin synthesis had no effect on the total peripheral vascular resistance, but markedly reduced renal blood flow, and increased the renal vascular resistance. Administration of indomethacin to animals without thoracic caval obstruction, on the other hand, had no effect on the renal blood flow.
In the aggregate, these data suggest that the renal prostaglandins were counteracting the vasoconstrictor mechanisms activated during acute heart failure and that after inhibition of renal prostaglandin synthesis the effect of the vasoconstrictor mechanisms acting elsewhere in the systemic circulation were also expressed in the renal circulation. Support for this interpretation derives from pharmacological studies indicating that prostaglandin inhibition potentiates the renal vasoconstrictor effects of exogenous angiotensin II (27, 28) , of norepinephrine (27) , and of renal nerve stimulation (14, 29) .
The data from the present study are also consonant with results obtained in other conditions in which there has been activation of the renin-angiotensin system. Renal prostaglandin synthesis is increased in sodium depletion (30) , hemorrhagic hypotension (31), renal artery constriction (31) , and cirrhosis with ascitis (33) . In all these conditions, administration of inhibitors of prostaglandin synthesis reduces renal blood flow (12, 15, 16, 31) . The mechanism(s) whereby the prostaglandins attenuate renal vasoconstrictor mechanisms remains to be determined. We have recently shown that the renal norepinephrine overflow is unchanged by inhibition of prostaglandin synthesis (34) , suggesting that the site of action where prostaglandins oppose the vascular effect of the sympathetic nerves is distal to the axon terminals. Since prostaglandins have intrinsic renal vasodilator action (17) , it is likely that they attenuate the renal vascular effects of norepinephrine and angiotensin II by directly acting upon the vascular smooth muscle cells.
The cellular origin of the PGE2 in the renal venous plasma and the stimuli responsible for the increase in the PGE2 concentration during decreased cardiac output remain to be defined. Biosynthesis of PGE2 has been demonstrated in vascular endothelial and smooth muscle cells (35, 36) , as well as renal interstitial cells (37) . It appears reasonable to postulate that the increased overflow of PGE2 into renal venous blood observed during the decrease of the cardiac output results, at least in part, from enhanced synthesis of PGE2 in the renal vasculature. The most likely stimuli responsible for this enhancement are the elevated levels of angiotensin II (renin) and norepinephrine. Angiotensin II stimulates PGE2 synthesis in in vitro conditions in endothelial (35) vascular smooth muscle (36) and renal interstitial (37) cells, and intrarenal infusions of angiotensin II cause increased biosynthesis of PGE2 in the kidney (32) . Similarly, intrarenal infusions of norepinephrine and renal nerve stimulation (38) enhance the release of PGE-like substances from the kidney and norepinephrine stimulates prostaglandin synthesis in isolated canine kidney cells (39) .
Although the glomerular filtration rate often does not change or decreases less than the renal plasma flow during acute heart failure (2), in the present study, the glomerular filtration rate fell considerably more than the renal plasma flow. This somewhat suprising finding has previously been reported in studies in which heart failure was induced in animals that received a moderate sodium load (4, 40) . Since the pressures and flows which determine the rate of glomerular filtration (41) were not measured in the present study, the mechanism responsible for the reduction of the glomerular filtration despite an unchanged renal plasma flow remains to be elucidated.
Despite the significant decrease in the renal plasma flow induced by inhibition of the prostaglandin synthesis in the dogs with acute heart failure, golmerular filtration did not change. This finding is in agreement with other studies in which inhibition of prostaglandins reduced renal blood flow but had no effect on glomerular filtration rate (28); however, it contrasts with the observations that prostaglandin blockade significantly reduced the glomerular filtration rate in dogs with hypotensive hemorrhage (14, 31) and in patients with Bartter's syndrome (42) , with the nephrotic syndrome (43) , and with cirrhosis with ascitis (16) .
In summary, the present study demonstrates that the acute lowering of cardiac output increased peripheral vascular resistance and arterial PRA and norepinephrine concentration. Renal venous PRA and plasma concentrations of norepinephrine and PGE2 were also augmented during acute heart failure. Despite the systemic vasoconstriction, renal vascular resistance was unaffected by decreasing the cardiac output. Administration of inhibitors of prostaglandin synthesis decreased PGE2 concentration in renal vein plasma and markedly reduced renal blood flow and increased renal vascular resistance, but had no significant effect upon total peripheral vascular resistance. The data suggest that the renal blood flow is maintained during acute Renal Prostaglandins during Acute Reduction of Cardiac Output 235 heart failure by the effect(s) of the enhanced renal prostaglandin synthesis to oppose the vasoconstrictor mechanisms acting elsewhere in the circulation.
